Pharmaceutical News

RSS

OroScience signs agreement with ACE Surgical Supply to market Periogenix periodontal wound dressing

OroScience plc (Palo Alto, CA), an oral care life science company, announced today that it has entered into an agreement with ACE Surgical Supply, Inc. (Brockton, MA) to market and distribute Periogenix periodontal wound dressing to clinicians in the United States and Canadian dental markets.

1 Jun 2010

Sticky gel composed of MPEG-pDHA may help seal wounds created by surgery: Study

A compound found in sunless tanning spray may help to heal wounds following surgery, according to new results published by plastic surgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City and biomedical engineers at Cornell University in Ithaca, N.Y., where the novel compound was developed.

1 Jun 2010

More insight into key receptor that influences effectiveness of serotonin-related antidepressants

University of Michigan scientists have provided the most detailed picture yet of a key receptor in the brain that influences the effectiveness of serotonin-related antidepressants, such as Prozac.

1 Jun 2010

EpiCept provides update on post-approval commitments requested by EMA for Ceplene

EpiCept Corporation today provided an update on the post-approval commitments requested by the European Medicines Agency as part of its marketing authorization for Ceplene (histamine dihydrochloride). Ceplene is approved in the EU for remission maintenance and prevention of relapse in adults with Acute Myeloid Leukemia in first complete remission.

1 Jun 2010

New study finds usage of antidepressants increases risk of miscarriage in pregnant women

A new study in CMAJ (Canadian Medical Association Journal) found a 68% increase in the overall risk of miscarriage in pregnant women using antidepressants.

1 Jun 2010

Ubichem Research receives approval for supply of cGMP radiolabelled APIs

Ubichem, a leading provider of chemistry services to the drug development sector, through its Hungarian operation - Ubichem Research - has successfully completed a regulatory inspection and is now approved for the supply of cGMP radiolabelled Active Pharmaceutical Ingredients (APIs).

31 May 2010

BPC mobilizes to ensure patient interests are put first in new BC PharmaCare drug review process

On the verge of a BC Government announcement on a new policy on generic medication pricing and a Long Term Pharmacy Agreement, the Better Pharmacare Coalition (BPC) is mobilizing its two million members to ensure Government keeps its promise that patient interests and input are reflected in the new BC PharmaCare drug review process.

31 May 2010

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.

29 May 2010

NSF International tests, certifies nutritional supplements to prevent unacceptable contaminants

Recent news coverage has consumers concerned about the alarming amount of contaminants, such as pesticides and heavy metals, being found in herbal supplements. NSF International, an independent, not-for-profit public health organization, helps ease these concerns by testing and certifying supplements to ensure they are free of undeclared substances and unacceptable contaminants.

29 May 2010

Teva invests £37 million to expand Ontario production plant

The world's largest generic pharmaceutical company is investing £37 million to expand its Stouffville, Ontario production plant.

29 May 2010

Researchers assess effects of statins on tendon rupture

Michigan State University researchers are studying the role that statins - lifesavers for tens of millions of Americans trying to lower their cholesterol - play in causing disabling tendon ruptures.

29 May 2010

Research to understand potential role of sexual lubricants in HIV transmission

Today at the 2010 International Microbicides Conference in Pittsburgh, Dezzutti presented the results of tests conducted with five of the most widely used lubricants, chosen from the results of an IRMA web-based survey that collected information on the lubricant preferences of nearly 9,000 men and women from over 100 countries. Dezzutti's findings indicated that some of the products studied had toxic effects on cells and rectal tissue.

29 May 2010

HUYA Bioscience International forms strategic partnership with School of Chinese Materia Medica of BUCM

HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovation, today announced a strategic partnership with the School of Chinese Materia Medica of the Beijing University of Chinese Medicine (BUCM). As one of a series of collaborations that HUYA has established with China's leading research and development institutions, the agreement demonstrates HUYA's visionary commitment to enabling and accelerating the global development and commercialization of novel biopharmaceutical products originating in China.

29 May 2010

Sunitinib not effective in patients with papillary RCC: Researchers

Of the more than 38,000 Americans diagnosed with renal cell carcinoma each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell form of kidney cancer known as papillary RCC, which accounts for 12 percent of all RCC, responds differently to sunitinib - a standard frontline treatment for RCC.

29 May 2010

Shire receives Paragraph IV Notice Letter from Zydus over filing of ANDA for generic LIALDA

Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter today from Zydus Pharmaceuticals USA, Inc. advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of Shire's 1.2g mesalamine delayed release tablets, LIALDA(R).

29 May 2010

FDA may seek criminal penalties against J & J for faulty recall of children's Tylenol, other medicines

The Wall Street Journal: "The Food and Drug Administration said it is weighing whether to seek criminal penalties against the Johnson & Johnson unit that made children's Tylenol and other over-the-counter kids' medicines recalled last month. Joshua Sharfstein, the FDA's principal deputy commissioner, told lawmakers at a hearing Thursday that J&J's McNeil Consumer Healthcare unit had a 'pattern of noncompliance' with good manufacturing practices.

29 May 2010

Today's Opinions: Never-events, Medicare 'propaganda' and drug copays

According to the Labor Department, overall inflation has averaged about 2.5 percent annually, and prescription drug prices have gone up about 3.6 percent each year, over that time frame. Co-pays, though, have increased four times faster than inflation (Peter J. Pitts, 5/28).

29 May 2010

Previous recommendations on H1N1 pandemic influenza vaccine still stand: SAGE

Previous recommendations on who should be vaccinated with the H1N1 pandemic influenza vaccine still stand according to the World WHO's Strategic Advisory Group of Experts on Immunization, the principal advisory group to WHO for development of policy related to vaccines and immunization.

28 May 2010

Study shows infants fed Enfamil LIPIL experience improved immune outcomes

Results of a new study released this week in the June 2010 issue of The Journal of Pediatrics show that infants fed Enfamil LIPIL containing DHA and ARA during the first year of life experienced improved immune outcomes, including improved respiratory health, versus infants fed the same formulation without these beneficial lipids - and this health benefit was shown for the first three years of life.

28 May 2010

Advanced Life Sciences expands partnership with U.S. Government to assess Restanza against STI's

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced the expansion of its collaboration with the U.S. Government to include the evaluation of Restanza's activity against sexually transmitted infections (STI's), such as gonorrhea.

28 May 2010

Pharmaceutical News

OroScience signs agreement with ACE Surgical Supply to market Periogenix periodontal wound dressing

Sticky gel composed of MPEG-pDHA may help seal wounds created by surgery: Study

More insight into key receptor that influences effectiveness of serotonin-related antidepressants

EpiCept provides update on post-approval commitments requested by EMA for Ceplene

New study finds usage of antidepressants increases risk of miscarriage in pregnant women

Ubichem Research receives approval for supply of cGMP radiolabelled APIs

BPC mobilizes to ensure patient interests are put first in new BC PharmaCare drug review process

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

NSF International tests, certifies nutritional supplements to prevent unacceptable contaminants

Teva invests £37 million to expand Ontario production plant

Researchers assess effects of statins on tendon rupture

Research to understand potential role of sexual lubricants in HIV transmission

HUYA Bioscience International forms strategic partnership with School of Chinese Materia Medica of BUCM

Sunitinib not effective in patients with papillary RCC: Researchers

Shire receives Paragraph IV Notice Letter from Zydus over filing of ANDA for generic LIALDA

FDA may seek criminal penalties against J & J for faulty recall of children's Tylenol, other medicines

Today's Opinions: Never-events, Medicare 'propaganda' and drug copays

Previous recommendations on H1N1 pandemic influenza vaccine still stand: SAGE

Study shows infants fed Enfamil LIPIL experience improved immune outcomes

Advanced Life Sciences expands partnership with U.S. Government to assess Restanza against STI's

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News